CMS is telling pharmacies and other stakeholders to start preparing now for an upcoming national coverage determination (NCD) under Part B for preexposure prophylaxis (PrEP) using antiretroviral drugs to prevent HIV, laying out coding and other implementation details the agency says pharmacies need to have in place so they won’t disrupt patient access when the NCD comes out. If finalized, the drugs will be immediately covered under Part B instead of Part D. If finalized, CMS says the NCD would...